Patents Assigned to Tweed, Inc.
  • Patent number: 11491118
    Abstract: The present technology generally relates to compositions comprising cannabinoids for relieving pain in a subject and to methods of using such compositions for relieving pain in a subject.
    Type: Grant
    Filed: August 5, 2021
    Date of Patent: November 8, 2022
    Assignee: TWEED INC.
    Inventors: Mark Andrew Hetherington, Chris Schnarr
  • Patent number: 11110069
    Abstract: The present technology generally relates to compositions comprising cannabinoids for relieving pain in a subject and to methods of using such compositions for relieving pain in a subject.
    Type: Grant
    Filed: November 1, 2019
    Date of Patent: September 7, 2021
    Assignee: TWEED INC.
    Inventors: Mark Andrew Hetherington, Chris Schnarr
  • Patent number: 10934554
    Abstract: The invention relates to novel genetically modified plants and methods or materials, such as polynucleotides, expression cassettes, or vectors for producing the same. Moreover, the invention relates to altering the content of cannabinoids in plants and to medical compositions derived from such plants. In particular embodiments, the present invention relates to cannabis plants having modified expression of tetrahydrocannabinolic acid (THCA) synthase and methods of modifying the amount of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in cannabis by modifying expression of THCA synthase.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: March 2, 2021
    Assignee: Tweed, Inc.
    Inventors: Ekaterina Alexandra Boudko, Thomas IV Shipley, Douglas Johnson